- Lobbying
- Lobbying by Sanofi-Aventis Australia Pty Ltd
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Nick Campbell Mr | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Amendment
Lobbying Issues
Agencies Lobbied
Type of Issue
Copyright
Health Issues
Pharmacy
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Copyright
Health Issues
Pharmacy
Amendment
Lobbying Issues
Agencies Lobbied
Type of Issue
Health Issues
Pharmacy
Trade (Domestic & Foreign)
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Health Issues
Pharmacy
Trade (Domestic & Foreign)
Registration
Issue(s) they said they’d lobby about: Privileged & Confidential
The Australian Government's policy of initiating court proceedings to recovered damages from innovative pharmaceutical companies in cases where patents covering pharmaceutical benefits scheme (PBS)- listed medicines have been found invalid following an initial grant of an interlocutory injunction which delayed the launch of generic products.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate